Peptide-2
General Information
DRACP ID DRACP00336
Peptide Name Peptide-2
Sequence IELLQARGGCXGGRRRRRRRR
Sequence Length 21
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Coupling peptide
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HL-60 | Adult acute myeloid leukemia; Acute myeloid leukemia | Leukemia | IC50=2.64 µM | MTT assay | 3 h | 1 |
NCI-H358 | Minimally invasive lung adenocarcinoma | Carcinoma | IC50=2.19 µM | MTT assay | 3 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X(11)=Pemetrexed
Chiral L
Physicochemical Information
Formula C96H178N48O23S
Absent amino acids DFHKMNPSTVWY
Common amino acids R
Mass 287174
Pl 12.8
Basic residues 9
Acidic residues 1
Hydrophobic residues 4
Net charge 8
Boman Index -12502
Hydrophobicity -155.71
Aliphatic Index 60.48
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22076954
Title New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells
Doi 10.1002/psc.1407
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available